- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07691684
Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement
2. juli 2026 oppdatert av: Hussein Salam Abdulraheem Twayej, University Of Anbar
Evaluation of the Efficacy of Intra-Articular Injection of Platelet-Rich Plasma Versus Dexamethasone With Local Anaesthetic in the Treatment of Internal Derangement of the Temporomandibular Joint: A Randomised Controlled Trial
This study looked at whether an injection into the jaw joint (temporomandibular joint, or TMJ) can help people who have pain, clicking, and difficulty opening their mouth due to a slipped joint disc.
Thirty patients were randomly assigned to receive one of three injections: platelet-rich plasma (PRP, made from the patient's own blood), a steroid medication (dexamethasone) with a local anesthetic, or a saline (salt water) injection as a comparison.
Pain, joint clicking, and mouth opening were measured before the injection and one week later.
The study found that both PRP and the steroid injection reduced pain and clicking more than saline, and PRP also improved how wide patients could open their mouth.
Studieoversikt
Status
Fullført
Forhold
Detaljert beskrivelse
This was a prospective, parallel-group, three-arm randomised controlled trial conducted at the outpatient clinics of the Maxillofacial and Oral Surgery Division, College of Dentistry, University of Anbar, Ramadi, Iraq.
Thirty temporomandibular joints (30 patients) with clinically diagnosed disc displacement with reduction, per DC/TMD Axis I criteria, were randomised 1:1:1 by an independent statistician using a computer-generated sequence, with allocation concealed via sequentially numbered opaque envelopes.
The outcome assessor was blinded to treatment allocation throughout follow-up.
Patients in the dexamethasone and saline arms were not informed of their specific assignment; full blinding was not feasible for the PRP arm due to the visible blood draw and processing required.
All three injections used an identical preauricular approach, injection site, needle gauge, and volume (1 mL) to standardise the procedural experience across groups.
Within- and between-group differences were analysed using the Wilcoxon signed-rank test and Kruskal-Wallis test with Dunn post-hoc comparisons.
This trial was registered retrospectively after enrolment and follow-up were complete.
Studietype
Intervensjonell
Registrering (Faktiske)
30
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Al Najaf
-
Ramadi, Al Najaf, Irak, 54001
- College of Dentistry, University of Anbar
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Inclusion Criteria:
- Skeletally mature patients aged 18 years or older
- Symptomatic TMJ internal derangement in the form of disc displacement with reduction (DDwR), diagnosed using DC/TMD Axis I clinical criteria
- TMJ arthralgia confirmed by pain reproduced on palpation or provoked by jaw movement
- Clicking sound detectable on palpation or auscultation during opening and closing movements
- Elimination or marked reduction of the click on mouth opening from a protruded position
Exclusion Criteria:
- Intra-articular injection within the previous six months
- Systemic inflammatory arthropathy
- Coagulopathy
- Active local infection
- Low platelet count
- Ongoing antiplatelet or anticoagulant therapy
- Pregnancy
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: PRP
Single intra-articular injection of 0.6 mL leukocyte-poor platelet-rich plasma (PRP) into the superior joint space via a preauricular approach.
|
Autologous platelet-rich plasma (1 mL) prepared from the patient's own venous blood by centrifugation, injected into the superior joint space of the temporomandibular joint under a standardised preauricular approach.
|
|
Aktiv komparator: Dexamethasone + Local Anaesthetic
Single intra-articular injection of dexamethasone 4 mg (0.5 mL) combined with lidocaine 2% (0.5 mL), total 1 mL, into the superior joint space.
|
Intra-articular injection (1 mL) of dexamethasone combined with a local anaesthetic, delivered into the superior joint space of the temporomandibular joint using the same standardised preauricular approach as the other study arms.
|
|
Placebo komparator: Normal Saline (Control)
Single intra-articular injection of 1 mL sterile 0.9% sodium chloride into the superior joint space, replicating the full procedural experience without an active agent.
|
Intra-articular injection (1 mL) of normal saline solution into the superior joint space of the temporomandibular joint, serving as the placebo control, using the same standardised preauricular approach as the other study arms.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Pain Intensity (VAS)
Tidsramme: Baseline and 1 week post-injection
|
Pain intensity rated on a 10-cm visual analogue scale (0=no pain, 10=worst imaginable pain), reflecting the most intense pain during function.
|
Baseline and 1 week post-injection
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Joint Sound (Clicking)
Tidsramme: Baseline and 1 week post-injection
|
Joint sound graded by a blinded assessor on a 3-point ordinal scale: 0=no clicking, 1=clicking detectable on palpation only, 2=clearly audible clicking.
|
Baseline and 1 week post-injection
|
|
Change in Maximum Interincisal Opening (MIO)
Tidsramme: Baseline and 1 week post-injection
|
Maximum interincisal opening measured in millimetres between upper and lower central incisors at maximum voluntary mouth opening.
|
Baseline and 1 week post-injection
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Sabah Alheeti, BDS, CABMS, FIBMS, Oral and Maxillofacial Surgery Department / College of Dentistry / University of Anbar
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
10. desember 2025
Primær fullføring (Faktiske)
9. april 2026
Studiet fullført (Faktiske)
9. april 2026
Datoer for studieregistrering
Først innsendt
2. juli 2026
Først innsendt som oppfylte QC-kriteriene
2. juli 2026
Først lagt ut (Faktiske)
9. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
9. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
2. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Muskel- og skjelettsykdommer
- Stomatognatiske sykdommer
- Muskelsykdommer
- Leddsykdommer
- Kjevesykdommer
- Underkjevesykdommer
- Kraniomandibulære lidelser
- Myofascial smertesyndrom
- Temporomandibulære leddsykdommer
- Temporomandibulært ledd dysfunksjonssyndrom
- Farmasøytiske preparater
- Polysykliske forbindelser
- Gravadienes
- Gravaner
- Steroider
- Smeltede ringforbindelser
- Steroider, fluorert
- Krystalloidløsninger
- Isotoniske løsninger
- Løsninger
- Anestesi og smertestillende
- Gravadienetrioler
- Anestesi, ledning
- Anestesi
- Deksametason
- Saltoppløsning
- Anestesi, lokal
Andre studie-ID-numre
- UoAnbar-TMJ-PRP-2025
- 141 (Annen identifikator: University of Anbar Ethical Approval Committee)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
IPD-planbeskrivelse
"The dataset supporting the conclusions of this article may be requested from the corresponding author"
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .